370 related articles for article (PubMed ID: 32004565)
21. Th2 Modulation of Transient Receptor Potential Channels: An Unmet Therapeutic Intervention for Atopic Dermatitis.
Meng J; Li Y; Fischer MJM; Steinhoff M; Chen W; Wang J
Front Immunol; 2021; 12():696784. PubMed ID: 34276687
[TBL] [Abstract][Full Text] [Related]
22. Transient Receptor Potential Vanilloid 4 Ion Channel Functions as a Pruriceptor in Epidermal Keratinocytes to Evoke Histaminergic Itch.
Chen Y; Fang Q; Wang Z; Zhang JY; MacLeod AS; Hall RP; Liedtke WB
J Biol Chem; 2016 May; 291(19):10252-62. PubMed ID: 26961876
[TBL] [Abstract][Full Text] [Related]
23. New therapies for controlling atopic itch.
Furue M; Kadono T
J Dermatol; 2015 Sep; 42(9):847-50. PubMed ID: 26332459
[TBL] [Abstract][Full Text] [Related]
24. Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch-related responses in mice with chronic atopy-like dermatitis.
Andoh T; Yoshida T; Kuraishi Y
Exp Dermatol; 2014 May; 23(5):359-61. PubMed ID: 24645735
[TBL] [Abstract][Full Text] [Related]
25. The CysLT
Voisin T; Perner C; Messou MA; Shiers S; Ualiyeva S; Kanaoka Y; Price TJ; Sokol CL; Bankova LG; Austen KF; Chiu IM
Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753496
[TBL] [Abstract][Full Text] [Related]
26. Persistent kallikrein 5 activation induces atopic dermatitis-like skin architecture independent of PAR2 activity.
Zhu Y; Underwood J; Macmillan D; Shariff L; O'Shaughnessy R; Harper JI; Pickard C; Friedmann PS; Healy E; Di WL
J Allergy Clin Immunol; 2017 Nov; 140(5):1310-1322.e5. PubMed ID: 28238749
[TBL] [Abstract][Full Text] [Related]
27. A TR(I)P to pruritus research: role of TRPV3 in inflammation and itch.
Steinhoff M; Bíró T
J Invest Dermatol; 2009 Mar; 129(3):531-5. PubMed ID: 19209153
[TBL] [Abstract][Full Text] [Related]
28. Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model.
Yamamoto Y; Otsuka A; Nakashima C; Ishida Y; Honda T; Egawa G; Amano W; Usui K; Hamada Y; Wada M; Tanimoto A; Konishi N; Hayashi M; Matsushita M; Kabashima K
J Dermatol Sci; 2020 Feb; 97(2):161-164. PubMed ID: 31924380
[No Abstract] [Full Text] [Related]
29. Agonists of proteinase-activated receptor-2 stimulate upregulation of intercellular cell adhesion molecule-1 in primary human keratinocytes via activation of NF-kappa B.
Buddenkotte J; Stroh C; Engels IH; Moormann C; Shpacovitch VM; Seeliger S; Vergnolle N; Vestweber D; Luger TA; Schulze-Osthoff K; Steinhoff M
J Invest Dermatol; 2005 Jan; 124(1):38-45. PubMed ID: 15654951
[TBL] [Abstract][Full Text] [Related]
30. Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitis.
Walsh CM; Hill RZ; Schwendinger-Schreck J; Deguine J; Brock EC; Kucirek N; Rifi Z; Wei J; Gronert K; Brem RB; Barton GM; Bautista DM
Elife; 2019 Oct; 8():. PubMed ID: 31631836
[TBL] [Abstract][Full Text] [Related]
31. Signal Transducer and Activator of Transcription 3 in Keratinocytes Regulates Histaminergic Itch but Not Nonhistaminergic Itch.
Hashimoto T; Sakai K; Yosipovitch G; Akiyama T
Acta Derm Venereol; 2019 Sep; 99(10):901-902. PubMed ID: 31141156
[No Abstract] [Full Text] [Related]
32. The Genetics of Chronic Itch: Gene Expression in the Skin of Patients with Atopic Dermatitis and Psoriasis with Severe Itch.
Nattkemper LA; Tey HL; Valdes-Rodriguez R; Lee H; Mollanazar NK; Albornoz C; Sanders KM; Yosipovitch G
J Invest Dermatol; 2018 Jun; 138(6):1311-1317. PubMed ID: 29317264
[TBL] [Abstract][Full Text] [Related]
33. Anti-pruritic and anti-inflammatory effects of natural verbascoside through selective inhibition of temperature-sensitive Ca
Sun X; Qi H; Wu H; Qu Y; Wang K
J Dermatol Sci; 2020 Mar; 97(3):229-231. PubMed ID: 31983608
[No Abstract] [Full Text] [Related]
34. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone.
Inagaki N; Shiraishi N; Igeta K; Itoh T; Chikumoto T; Nagao M; Kim JF; Nagai H
Eur J Pharmacol; 2006 Sep; 546(1-3):189-96. PubMed ID: 16914137
[TBL] [Abstract][Full Text] [Related]
35. Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.
Zhao P; Lieu T; Barlow N; Metcalf M; Veldhuis NA; Jensen DD; Kocan M; Sostegni S; Haerteis S; Baraznenok V; Henderson I; Lindström E; Guerrero-Alba R; Valdez-Morales EE; Liedtke W; McIntyre P; Vanner SJ; Korbmacher C; Bunnett NW
J Biol Chem; 2014 Sep; 289(39):27215-27234. PubMed ID: 25118282
[TBL] [Abstract][Full Text] [Related]
36. Epithelia-Sensory Neuron Cross Talk Underlies Cholestatic Itch Induced by Lysophosphatidylcholine.
Chen Y; Wang ZL; Yeo M; Zhang QJ; López-Romero AE; Ding HP; Zhang X; Zeng Q; Morales-Lázaro SL; Moore C; Jin YA; Yang HH; Morstein J; Bortsov A; Krawczyk M; Lammert F; Abdelmalek M; Diehl AM; Milkiewicz P; Kremer AE; Zhang JY; Nackley A; Reeves TE; Ko MC; Ji RR; Rosenbaum T; Liedtke W
Gastroenterology; 2021 Jul; 161(1):301-317.e16. PubMed ID: 33819485
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice.
Costa R; Marotta DM; Manjavachi MN; Fernandes ES; Lima-Garcia JF; Paszcuk AF; Quintão NL; Juliano L; Brain SD; Calixto JB
Br J Pharmacol; 2008 Jul; 154(5):1094-103. PubMed ID: 18454165
[TBL] [Abstract][Full Text] [Related]
38. Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes.
Szöllősi AG; Vasas N; Angyal Á; Kistamás K; Nánási PP; Mihály J; Béke G; Herczeg-Lisztes E; Szegedi A; Kawada N; Yanagida T; Mori T; Kemény L; Bíró T
J Invest Dermatol; 2018 Feb; 138(2):365-374. PubMed ID: 28964718
[TBL] [Abstract][Full Text] [Related]
39. Potentiation of the transient receptor potential vanilloid 1 channel contributes to pruritogenesis in a rat model of liver disease.
Belghiti M; Estévez-Herrera J; Giménez-Garzó C; González-Usano A; Montoliu C; Ferrer-Montiel A; Felipo V; Planells-Cases R
J Biol Chem; 2013 Apr; 288(14):9675-9685. PubMed ID: 23408423
[TBL] [Abstract][Full Text] [Related]
40. Scutellarein attenuates atopic dermatitis by selectively inhibiting transient receptor potential vanilloid 3 channels.
Wang Y; Tan L; Jiao K; Xue C; Tang Q; Jiang S; Ren Y; Chen H; El-Aziz TMA; Abdelazeem KNM; Yu Y; Zhao F; Zhu MX; Cao Z
Br J Pharmacol; 2022 Oct; 179(20):4792-4808. PubMed ID: 35771623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
